Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective

Muhammad Rizwan Alam1, Delphine Baetz1, Michel Ovize2

  • 1INSERM U1060, CarMeN Laboratory, Claude Bernard Lyon 1 University, F-69373 Lyon, France.

Insights

Cyclophilin D (CypD) is crucial for mitochondrial permeability transition pore (mPTP) opening during ischemia-reperfusion (IR) injury. Targeting CypD offers therapeutic potential for reducing cardiac IR damage.

Area of Science:

  • Mitochondrial biology
  • Cardiovascular disease
  • Cell death mechanisms

Background:

  • Ischemia-reperfusion (IR) injury involves ion deregulation and reactive oxygen species, leading to cell death.
  • The mitochondrial permeability transition pore (mPTP) mediates IR-induced necrotic cell death.
  • Cyclophilin D (CypD) is the sole confirmed regulator of mPTP induction.

Purpose of the Study:

  • To review CypD's role in mPTP formation and cardiac IR injury.
  • To discuss recent findings on CypD's additional functions.
  • To highlight therapeutic strategies targeting CypD in myocardial IR injury.

Main Methods:

  • Literature review of existing knowledge on CypD and mPTP.
  • Analysis of recent research on CypD interactions and modifications.
  • Synthesis of information on therapeutic interventions targeting CypD.

Main Results:

  • CypD is a key mediator of mPTP opening in cardiac IR injury.
  • CypD has diverse functions influenced by interaction partners and post-translational modifications.
  • Targeting CypD presents a promising therapeutic avenue for myocardial IR injury.

Conclusions:

  • CypD plays a central role in the pathophysiology of cardiac IR injury.
  • Understanding CypD's multifaceted roles is essential for developing effective treatments.
  • Therapeutic strategies focused on CypD hold significant promise for mitigating heart damage after IR events.